Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

BioMarin Pharmaceutical Inc. (BMRN)

76.08   0.08 (0.11%) 10-01 09:21
Open: 76.15 Pre. Close: 76
High: 77.555 Low: 75.4301
Volume: 1,561,523 Market Cap: 13,797M
BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. The company is headquartered in Novato, California and currently employs 2,849 full-time employees. The firm develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The firm is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 78.454 - 78.904 78.904 - 79.31
Low: 74.976 - 75.461 75.461 - 75.899
Close: 75.811 - 76.59 76.59 - 77.293

Technical analysis

as of: 2020-09-30 4:39:19 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 94.54     One year: 110.42
Support: Support1: 75.01    Support2: 71.35
Resistance: Resistance1: 80.94    Resistance2: 94.54
Pivot: 76.41
Moving Average: MA(5): 77.38     MA(20): 76.32
MA(100): 103.55     MA(250): 90.83
MACD: MACD(12,26): -3.88     Signal(9): -5.45
Stochastic oscillator: %K(14,3): 62.00     %D(3): 62.68
RSI: RSI(14): 38.29
52-week: High: 131.95  Low: 63.08  Change(%): 19.0
Average Vol(K): 3-Month: 239406  10-Days: 226591

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BMRN has closed below upper band by 48.9%. Bollinger Bands are 58.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMRN's normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 30 Sep 2020
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of BioMarin Pharmaceutical Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 24, 2020 - BMRN - Yahoo Finance

Wed, 30 Sep 2020
BIOMARIN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRN - Business Wire

Wed, 30 Sep 2020
Here is why BioMarin Pharmaceutical Inc. (BMRN) recent weekly performance of -4.23% shouldn’t bother you at All - The InvestChronicle

Wed, 30 Sep 2020
Portnoy Law: Lawsuit Filed On Behalf of BioMarin Pharmaceutical, Inc. Investors - GlobeNewswire

Wed, 30 Sep 2020
BMRN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BioMarin Pharmaceutical Inc. Investors of Class Action and Lead Plaintiff Deadline: November 24, 2020 - PRNewswire

Tue, 29 Sep 2020
BioMarin Pharmaceutical Inc. (BMRN): Skating on Thin Ice? We Know the Answer - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 181
Shares Float (M) 180
% Held by Insiders 0.49
% Held by Institutions 99.30
Shares Short (K) 10,300
Shares Short P. Month (K) 9,960

Stock Financials

EPS 0.680
EPS Est This Year -0.740
EPS Est Next Year -0.240
Book Value (p.s.) 17.870
Profit Margin 6.62
Operating Margin -0.53
Return on Assets (ttm) -0.1
Return on Equity (ttm) 4.0
Qtrly Rev. Growth 10.8
Gross Profit (p.s.) 3.472
Sales Per Share 10.201
EBITDA (p.s.) 0.540
Qtrly Earnings Growth
Operating Cash Flow (M) 140
Levered Free Cash Flow (M) -82

Stock Valuations

PE Ratio 112.51
PEG Ratio 0.82
Price to Book value 4.28
Price to Sales 7.50
Price to Cash Flow 99.10

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.